By Josh White
Date: Thursday 14 Mar 2024
(Sharecast News) - Halma reiterated its guidance in a trading update on Thursday, maintaining its projection for adjusted profit before tax to align with analyst consensus expectations.
Halma buys Rovers Medical for €85m | 04-Mar-2024 | ShareCast |
London close: Stocks mixed ahead of Autumn State... | 20-Nov-2023 | ShareCast |
Halma buys US-based TeDan for up to $100m | 20-Nov-2023 | ShareCast |
London close: Stocks sink after three days of ga... | 16-Nov-2023 | ShareCast |
Halma posts record first-half results amid growt... | 16-Nov-2023 | ShareCast |
Director/PDMR Shareholding | 19-Mar-2024 | 15:53 | RNS |
Trading Update | 14-Mar-2024 | 07:00 | RNS |
Acquisition | 04-Mar-2024 | 07:00 | RNS |
Director/PDMR Shareholding | 21-Feb-2024 | 16:17 | RNS |
Directorate Change | 30-Jan-2024 | 07:00 | RNS |
BNS board increase holding in bid to boost share... | 26-Mar-2006 | Scotland on Sunday |
Investment Column:Halma | 12-Jul-2011 | The Independent |
Investment Column:Halma | 01-Dec-2010 | The Independent |
Tempus:Halma | 04-Dec-2009 | Times |
Investment Column:Halma | 17-Jun-2009 | The Independent |
Investment Column:Halma | 28-Nov-2008 | The Independent |
No recent information was found.
Currency | UK Pounds |
Share Price | 2,368.00p |
Change Today | 32.00p |
% Change | 1.37 % |
52 Week High | 2,498.00 |
52 Week Low | 1,810.50 |
Volume | 927,873 |
Shares Issued | 379.65m |
Market Cap | £8,990m |
RiskGrade | 112 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 2 |
Buy | 0 |
Neutral | 11 |
Sell | 1 |
Strong Sell | 1 |
Total | 15 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 21-Dec-23 | 13-Jul-23 |
Paid | 02-Feb-24 | 18-Aug-23 |
Amount | 8.41p | 12.34p |
Time | Volume / Share Price |
16:35 | 745,518 @ 2,368.00p |
16:35 | 444 @ 2,368.00p |
16:35 | 320 @ 2,368.00p |
16:35 | 6,563 @ 2,368.00p |
16:35 | 1,686 @ 2,368.00p |
CEO | Marc Ronchetti |
Chair | Dame Louise Makin |
CFO | Steve Gunning |
You are here: research